
Spine
Gabapentinoids, topiramate do not demonstrate significant effect on pain and disability in LBP
This report has been verified
by one or more authors of the
original publication.
CMAJ. 2018 Jul 3;190(26):E786-E793. doi: 10.1503/cmaj.171333
Nine randomized controlled trials were included in the meta-analysis and systematic review, which was conducted to analyze the effects of anticonvulsants - including gabapentinoids and topiramate - in patients with either nonspecific low back pain or lumbar radicular pain secondary to spinal stenosis. Results on gabapentinoids demonstrated no significant differences relative to placebo on either pain or disability measures in patients with either pathology, coupled with a significant increase in the rate of adverse events. Results on topiramate demonstrated a statistically significant effect on immediate pain relative to placebo in patients with nonspecific low back pain, though differences thereafter were not significant. Additionally, no significant effect of topiramate compared to placebo was observed among patients with lumbar radicular pain.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.